Search the Newsreel

(EXEL) as a Liquidity Pulse for Institutional Tactics

This article analyzes Exelixis Inc. (NASDAQ: EXEL) using AI models to provide institutional trading strategies. It highlights a weak near-term sentiment but strong long-term outlook, with a significant 26.9:1 risk-reward setup. Three distinct strategies—Position Trading, Momentum Breakout, and Risk Hedging—are detailed, alongside multi-timeframe signal …

Assenagon Asset Management S.A. Has $23.57 Million Stake in Exelon Corporation $EXC

Assenagon Asset Management S.A. significantly increased its stake in Exelon Corporation by 133.9% in the second quarter, bringing its total holdings to 505,564 shares valued at $23.57 million. Despite this, institutional investors collectively own 80.92% of Exelon, while analyst sentiment remains cautious with a …

Crexendo: Positive Q2 Results And Outlook Could Drive Strong Stock Gains (NASDAQ:CXDO)

¿Han cambiado los resultados dispares del segundo trimestre y las agresivas recompras de acciones el panorama de la política de retorno de capital de Expand Energy (EXE)?

Extendicare Q2 Earnings Call Highlights

Key Points Interested in Extendicare Inc.? Here are five stocks we like better. Strong Q2 growth: Revenue increased 59.4% to C$611 million and adjusted EBITDA rose 71% to C$68.3 million, driven by full-quarter contributions from CBI Home Health, Revera homes and Closing the Gap. …

Exelon (EXC) Could Be 8% Undervalued Following Second Quarter Earnings

Crexendo Inc (CXDO) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Crexendo Inc (CXDO), indicating a current earnings forecast score of 8.00 and an average price target of $9.00 based on 6 analysts. Most analysts recommend a "Buy" for CXDO, with an expected revenue of $25.14M for the …

Exelon Corp (EXC) Stock News Today

This article provides current stock news for Exelon Corp (EXC), an electric utility company. As of August 10th, EXC closed at $44.855, showing a slight increase, with a market capitalization of $46.29 billion. The latest news highlights that GE Vernova Inc stock (GEV) experienced …

Did Stronger Q2 Earnings and Lowered 2026 Guidance Just Recast Exelixis' (EXEL) Oncology Narrative?

EXELIXIS ($EXEL) announced its Q2 2026 earnings, reporting $0.91 per share, which surpassed estimates. However, the company's revenue of $628.69 million fell short of expectations. Following the announcement, the stock experienced a 5.23% decline.

Assenagon Asset Management S.A. Has $107.89 Million Stock Position in Expand Energy Corporation $EXE

Assenagon Asset Management S.A. significantly increased its stake in Expand Energy Corporation (NASDAQ:EXE) by 882.2% in the second quarter, bringing its total holdings to 1.18 million shares valued at approximately $107.9 million. Expand Energy also reported strong quarterly earnings, exceeding expectations with $1.33 EPS …

Lexeo Therapeutics Inc (LXEO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Lexeo Therapeutics Inc (LXEO) has an earnings forecast score of 9.20, ranking 9th in its industry. Analysts have set an average price target of $18.50, with a strong buy recommendation. The company's previous EPS was -$0.27, and the next quarter's EPS is expected to …

Extendicare (TSX:EXE) Stock Sees Cash Flow Strength As Debt Risks Linger

Crexendo Inc (CXDO) Stock News Today

This article provides the latest news and financial data for Crexendo Inc (CXDO), a software and IT services company. It highlights the company's recent Q2 2026 earnings, where service revenue drove a 49% growth. The current stock price, market capitalization, and P/E ratio are …

Exelixis, Inc. Stock 12‑Month Price Target Raised to $52.62, Implies 7% Downside

Exelixis, Inc.'s average stock price target has been raised from $52.25 to $52.62 by 16 analysts, suggesting a potential 7% downside based on the August 5 closing price. Despite the raised target implying a decrease, the consensus rating for EXEL remains a "Buy" from …

EXELIXIS INC EXELIXIS ORD SHS (0IJO.L) Q4 FY2025 earnings call transcript

Exelixis reported Q4 2025 revenues of $599M, primarily driven by a 6% year-over-year increase in U.S. CABOMETYX sales to $547M, with full-year 2025 U.S. CABOMETYX revenue reaching $2.12B, up 17% year-over-year. The company is preparing for a potential late 2026 launch of zanzalintinib for …

Quantinno Capital Management LP Boosts Holdings in Exelixis, Inc. $EXEL

Quantinno Capital Management LP significantly increased its stake in Exelixis, Inc. by 44.3% in the first quarter, now holding 115,592 shares valued at approximately $4.96 million. This increase occurred despite mixed analyst ratings and recent insider selling. Exelixis reported strong second-quarter adjusted earnings but …

State Street Corporation (NASDAQ: EXE) reports 6.5% Expand Energy ownership on Schedule 13G

State Street Corporation has reported a 6.5% passive ownership stake in Expand Energy Corp (NASDAQ: EXE) common stock through a Schedule 13G filing. This represents 15,631,873 beneficially owned shares, with shared voting power over 11,794,045 shares and shared dispositive power over 15,619,193 shares. The …

Exelon Corporation $EXC Holdings Decreased by Bank of America Corp DE

Bank of America Corp DE reduced its stake in Exelon Corporation by 19.8% in the first quarter, selling 1.57 million shares and retaining 6.34 million shares valued at $310.6 million. Despite this, Exelon reported a 10% year-over-year revenue increase to $5.97 billion in Q2 …

EXELIXIS INC : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM

Leerink Partners has downgraded its rating for Exelixis Inc (EXEL.O) from "Outperform" to "Market Perform." This change indicates a revised outlook on the pharmaceutical company's stock performance. The update was reported by Reuters.

Crexendo, Inc. (CXDO) CEO RSUs vest as 68 shares withheld for taxes

Crexendo, Inc. CEO Jeffrey G. Korn reported the vesting of 278 Restricted Stock Units (RSUs) into common stock on August 4, 2026. The company withheld 68 shares, valued at $7.47 each, to cover payroll tax obligations, a transaction explicitly stated not to be a …

Crexendo (CXDO) CFO notes 278 RSUs vested, 118 shares withheld for taxes

Crexendo, Inc.'s CFO, Vincent Ron, reported the vesting of 278 Restricted Stock Units (RSUs) on August 4, 2026. The company withheld 118 common shares at $7.47 per share to cover payroll taxes, clarifying that this was not a market sale. Ron retains 8,334 RSUs, …

Exelixis (EXEL) Is Down 6.7% After Cutting 2026 Revenue Outlook Amid Oncology Investment Pivot

Exelixis (EXEL) saw its stock drop 6.7% after cutting its 2026 revenue outlook to $2.50 billion–$2.55 billion. This revision came despite solid Q2 earnings and is attributed to slower growth in the neuroendocrine tumor indication and continued heavy investment in its zanzalintinib pipeline and …

EXELIXIS, INC. Q2 2026: Revenue $628.69M, EPS $0.82— 10-Q Summary

EXELIXIS, INC. reported strong second-quarter 2026 results with revenue of $628.69M and diluted EPS of $0.82, showing significant year-over-year growth due to increased product demand and price gains. Key drivers included CABOMETYX sales, progress in pipeline development with zanzalintinib, and expanded clinical trials. The …

Exelixis Inc (EXEL) Beats EPS Estimate with $0.82 and Reports Revenue of $628.7 Million -- Is the Stock Overvalued?

Exelixis Inc (EXEL) reported strong financial results for Q2 2026, surpassing analyst expectations with total revenues of $628.7 million and a GAAP diluted EPS of $0.82. The biopharmaceutical company, known for its cancer treatments like cabozantinib, updated its fiscal year 2026 guidance, projecting total …

Crexendo (CXDO) Stock Drops As Growth Strengthens But Earnings Lag

Crexendo (CXDO) stock recently dropped 11% despite strong Q2 2026 financial results, including a 48.9% revenue increase and a 17% adjusted EBITDA margin. While bulls point to significant growth in service and software solutions, bears highlight modest organic revenue growth and shifts in product …

Exelixis, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:EXEL) 2026-08-06

Exelixis, Inc. published its Q2 2026 earnings call presentation. The company reported EPS of $0.91, beating estimates by $0.02, but revenue of $628.69M missed expectations by $7.46M, despite a 10.63% year-over-year increase. The slide deck provides detailed information discussed during the earnings call.

Analysts Offer Insights on Communication Services Companies: Crexendo (CXDO), Pinterest (PINS) and Spotify (SPOT)

This article provides an overview of recent analyst ratings for three communication services companies: Crexendo (CXDO), Pinterest (PINS), and Spotify (SPOT). Crexendo received a "Strong Buy" consensus with a $11.00 average price target, Pinterest a "Moderate Buy" with a $29.00 average price target, and …

EXEL Tops Q2 Earnings Estimates, Misses on Sales, Lowers '26 View

Exelixis, Inc. (EXEL) reported mixed results for Q2 2026, beating earnings estimates with 82 cents EPS but missing revenue forecasts at $628.7 million. The company lowered its full-year 2026 revenue guidance due to a slower-than-expected ramp-up of its neuroendocrine tumor indication for Cabometyx. Despite …

Responsive Playbooks and the CXDO Inflection

This article provides an AI-generated analysis of Crexendo Inc. (NASDAQ: CXDO), highlighting positive near-term sentiment within a long-term strong context, despite a weak mid-term bias. It outlines exceptional risk-reward setups, specific trading strategies (Position, Momentum Breakout, Risk Hedging) with entry/target/stop-loss zones, and a multi-timeframe …

Q2 2026 Exelon Corp Earnings Call Transcript

Exelon Corp (EXC) reported Q2 2026 adjusted operating earnings of $0.43 per share, meeting expectations, and reaffirmed its full-year guidance. The company demonstrated strong operational reliability, advanced a significant battery storage project in New Jersey, and implemented Transmission Security Agreements to manage speculative data …

Exelon Corporation $EXC Stake Reduced by Janus Henderson Group PLC

Janus Henderson Group PLC reduced its stake in Exelon Corporation (NASDAQ:EXC) by 36% in the first quarter, selling 98,894 shares and retaining 175,992 shares valued at $8.6 million. Despite this reduction, institutional investors collectively own 80.92% of Exelon. Analysts currently maintain a consensus "Hold" …

Expand Energy Number of Employees 2026 | Employee Count & Headcount Data

Expand Energy Corp. (EXE) had approximately 1,613 employees worldwide as of March 2026, a 10.8% decline from 2023. The company is actively hiring, with 69 active job postings in 2026, a 60.4% increase from 2025. Expand Energy's workforce is concentrated in the United States, …

Lexeo Therapeutics (LXEO) Projected to Release Earnings on Thursday

Lexeo Therapeutics (LXEO) is expected to release its Q2 2026 earnings before market open on Thursday, August 13th, with analysts projecting a loss of $0.30 per share. The company, currently unprofitable with a market capitalization of $349 million, has a "Buy" consensus rating and …

Zacks Research Predicts Exelixis' Q3 Earnings (NASDAQ:EXEL)

Exelixis (EXEL) Stock Drops As Guidance Cut Clouds Profit Strength

What Exelon Corporation’s Q2 Earnings Call Revealed About the Next PJM Auction